Health officials in England have detected a newly evolved variant of mpox after testing a person who had recently travelled to Asia. Genome analysis revealed that the virus is a recombinant form, combining genetic material from two known strains: the more severe clade 1 and the less virulent clade 2, the latter responsible for the global mpox outbreak in 2022.
The UK Health Security Agency stated that further study is underway to assess how significant this new strain may be. Experts say virus evolution is expected, especially when multiple variants circulate at the same time.
Mpox, formerly known as monkeypox, is related to smallpox and spreads through close physical contact, contaminated materials such as bedding or clothing, or through respiratory droplets. Symptoms may take up to three weeks to appear, typically beginning with fever, headache, muscle pain and fatigue, followed by a rash.
While most infections remain mild, officials encourage eligible individuals, particularly those with higher exposure risks, to get vaccinated. The variant’s emergence highlights the need for continued monitoring as the virus evolves.
The World Health Organization recorded almost 48,000 confirmed mpox cases worldwide in 2025. Researchers emphasise that if more cases of this recombinant strain appear, it will be essential to understand how it spreads and whether it causes more severe illness than previous variants.
